Moderna says its COVID-19 shot works in kids as young as 12

13 Sept 09:06 Key points summarised by AI

Moderna announced its COVID-19 vaccine demonstrated strong protection and safety for adolescents aged 12-17 in recent clinical trials.
The company plans to submit its data to U.S. and global regulators, positioning its shot as a potential second vaccine option for this age group.
Trial findings revealed 100% efficacy against COVID-19 after two doses, with immune responses and temporary side effects consistent with those observed in adults.
This development is crucial for expanding vaccination efforts to younger populations, as children represent a significant portion of coronavirus cases.

Suchada: Meet the reluctant star of Thailand’s cryptic crypto drama

Yesterday 15:38 Key points summarised by AI

Thai MP Suchada Zhang Thaensap faces intense scrutiny over her husband’s substantial 1.84 billion baht wealth, with opposition lawmakers alleging connections to international scam networks.
A significant portion of her husband, Taiyang Zhang's, declared assets includes a 1.44 billion baht loan to the now-bankrupt cryptocurrency hedge fund Three Arrows Capital, which still owes him 1.34 billion baht.
Opposition MP Rangsiman Rome accused Suchada's husband of links to online scam networks and gambling sites, prompting Suchada to vehemently deny the claims, demand evidence, and file a defamation complaint.
Taiyang Zhang's background includes co-founding Ren Protocol, later sold to Alameda Research (linked to the FTX collapse), and some of his former associates have been convicted in crypto company failures.
Suchada, a former actress and first-time MP, maintains her husband's innocence, while her party leaders have distanced themselves from the allegations, deeming it a private matter.